FUTURE Trials Lead to Novel Treatment for Psoriatic Arthritis
Results from the FUTURE trials demonstrate significant reduction in disease burden and severity of PsA with secukinumab.
All articles by Linda Peckel
Bone Modulation Strategies for the Prevention of Osteoporosis-Associated Fractures
Nearly half of all fractures in women over age 50 are associated with osteoporosis.
DMARDS Remain First Choice Compared to Biologic Therapies for RA
Which agent—DMARD or biologic—or combination is best for a patient with rheumatoid arthritis?
Next post in Rheumatoid Arthritis
